Literature DB >> 24421493

Melatonin: delirium (postsurgical).

Joyce A Generali1, Dennis J Cada2.   

Abstract

This Hospital Pharmacy feature is extracted from Off-Label Drug Facts,a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@kumc.edu.

Entities:  

Year:  2013        PMID: 24421493      PMCID: PMC3839466          DOI: 10.1310/hpj4805-378

Source DB:  PubMed          Journal:  Hosp Pharm        ISSN: 0018-5787


  4 in total

Review 1.  Perioperative melatonin use.

Authors:  J Jarratt
Journal:  Anaesth Intensive Care       Date:  2011-03       Impact factor: 1.669

2.  Assessment of role of perioperative melatonin in prevention and treatment of postoperative delirium after hip arthroplasty under spinal anesthesia in the elderly.

Authors:  Sherif S Sultan
Journal:  Saudi J Anaesth       Date:  2010-09

3.  Perioperative plasma melatonin concentration in postoperative critically ill patients: its association with delirium.

Authors:  Shiho Yoshitaka; Moritoki Egi; Hiroshi Morimatsu; Tomoyuki Kanazawa; Yuichiro Toda; Kiyoshi Morita
Journal:  J Crit Care       Date:  2013-01-09       Impact factor: 3.425

Review 4.  Clinical practice guidelines for the management of pain, agitation, and delirium in adult patients in the intensive care unit.

Authors:  Juliana Barr; Gilles L Fraser; Kathleen Puntillo; E Wesley Ely; Céline Gélinas; Joseph F Dasta; Judy E Davidson; John W Devlin; John P Kress; Aaron M Joffe; Douglas B Coursin; Daniel L Herr; Avery Tung; Bryce R H Robinson; Dorrie K Fontaine; Michael A Ramsay; Richard R Riker; Curtis N Sessler; Brenda Pun; Yoanna Skrobik; Roman Jaeschke
Journal:  Crit Care Med       Date:  2013-01       Impact factor: 7.598

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.